(Q50587062)

16 March 2018

title

Interferon plus ribavirin in chronic hepatitis C non-responders to recombinant alpha-interferon. (English)

1 reference

16 March 2018

1 reference

1 reference

G Bresci

1

1 reference

16 March 2018

G Parisi

2

1 reference

16 March 2018

M Bertoni

3

1 reference

16 March 2018

F Scatena

4

1 reference

16 March 2018

A Capria

5

1 reference

16 March 2018

publication date

1 January 2000

1 reference

16 March 2018

Journal of Viral Hepatitis

published in

1 reference

16 March 2018

volume

7

1 reference

16 March 2018

issue

1

1 reference

16 March 2018

page(s)

75-78

1 reference

16 March 2018

Other approaches to the treatment of chronic viral hepatitis

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00212.X

Retreatment with interferon-alpha of chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00212.X

A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00212.X

Ribavirin and interferon-alpha combination therapy vs interferon-alpha alone in the retreatment of chronic hepatitis C: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00212.X

Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00212.X

An immunoassay for specific amplified HCV sequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00212.X

Evaluation and comparison of different hepatitis C virus genotyping and serotyping assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00212.X

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00212.X

Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00212.X

Hepatocellular carcinoma: Recent progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00212.X

Interferon-ribavirin combination therapy for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00212.X

Prediction of the response of chronic hepatitis C to interferon alfa: a statistical analysis of pretreatment variables.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00212.X

Interferon-alpha plus ribavirin in chronic hepatitis C resistant to previous interferon-alpha course: results of a randomized multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00212.X

10.1046/J.1365-2893.2000.00212.X

21 January 2018

Identifiers

DOI

1 reference

16 March 2018

1 reference

16 March 2018